121 related articles for article (PubMed ID: 34256990)
1. Local anesthesia for percutaneous US/CT-guided bipolar radiofrequency ablation of small renal masses: A safe and feasible alternative.
Sun Y; Wang W; Zhang Q; Zhao X; Zhu G; Hao J; Kan Y; Guo H
Urol Oncol; 2021 Oct; 39(10):734.e19-734.e24. PubMed ID: 34256990
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
3. Different effects of intravenous and local anesthesia in patients undergoing ultrasound-guided radiofrequency ablation of thyroid nodules: a prospective cohort study.
Gao S; Zhu Y; Tong M; Wang L; Ren S; Rui L; Yang F; Lian Z; Che Y
Int J Hyperthermia; 2022; 39(1):1036-1043. PubMed ID: 35938345
[TBL] [Abstract][Full Text] [Related]
4. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.
Lyrdal D; Andersson M; Hellström M; Sternal J; Lundstam S
Acta Radiol; 2010 Sep; 51(7):808-18. PubMed ID: 20707665
[TBL] [Abstract][Full Text] [Related]
6. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
7. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience.
Filippiadis D; Charalampopoulos G; Tsochatzis A; Reppas L; Mazioti A; Kelekis A; Kelekis N
Br J Radiol; 2021 May; 94(1121):20200445. PubMed ID: 33756082
[TBL] [Abstract][Full Text] [Related]
9. MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
Li Z; Wang C; Li J; Liu Z; Jiao D; Han X
BMC Cancer; 2021 May; 21(1):562. PubMed ID: 34001036
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ultrasound-guided 'three-step' radiofrequency ablation for giant hepatic hemangioma (5-15 cm): a safe and effective new technique.
Qu C; Liu H; Li XQ; Feng K; Ma K
Int J Hyperthermia; 2020; 37(1):212-219. PubMed ID: 32106730
[No Abstract] [Full Text] [Related]
11. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
[TBL] [Abstract][Full Text] [Related]
12. Split renal function after treatment of small renal masses: comparison between radiofrequency ablation and laparoscopic partial nephrectomy.
Acosta Ruiz V; Båtelsson S; Onkamo E; Wernroth L; Nilsson T; Lönnemark M; Dahlman P; Magnusson A
Acta Radiol; 2021 Sep; 62(9):1248-1256. PubMed ID: 32910686
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided biopsy for small renal masses before or immediately after tumor ablation: factors affecting diagnostic yield.
Takafuji M; Fujimori M; Nakatsuka A; Kodama H; Yamanaka T; Sugino Y; Matsushita N; Kanda H; Hirokawa Y; Sakuma H
Jpn J Radiol; 2021 Mar; 39(3):283-292. PubMed ID: 33025338
[TBL] [Abstract][Full Text] [Related]
15. Bipolar Radiofrequency Ablation of Painful Spinal Bone Metastases Performed under Local Anesthesia: Feasibility Regarding Patient's Experience and Pain Outcome.
Kastler A; Barbé DA; Alemann G; Hadjidekov G; Cornelis FH; Kastler B
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577889
[No Abstract] [Full Text] [Related]
16. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.
Huo J; Aloia TA; Xu Y; Chung TH; Sheu T; Tina Shih YC
Value Health; 2019 Mar; 22(3):284-292. PubMed ID: 30832966
[TBL] [Abstract][Full Text] [Related]
17. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
18. Utility of Intraprocedural Contrast-Enhanced CT in Ablation of Renal Masses.
Grewal A; Khera SS; McGahan JP; Wilson M; Loehfelm TW; Dall'Era MA; Evans CP
AJR Am J Roentgenol; 2020 Jan; 214(1):122-128. PubMed ID: 31532258
[No Abstract] [Full Text] [Related]
19. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
